Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Proof of Concept and Dose Ranging Study of Carbidopa-levodopa in Neovascular AMD

NCT03023059 is registered in ClinicalTrials.gov with Snyder, Robert W., M.D., Ph.D., P.C. as lead sponsor.

NCT NCT03023059
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03023059 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Proof of Concept and Dose Ranging Study of Carbidopa-levodopa in Neovascular AMD
Lead sponsor
Snyder, Robert W., M.D., Ph.D., P.C.
Phase
Phase 2
Overall status
Completed
Start date
May 2, 2017
Completion date
May 4, 2020
Enrollment
35 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

age-related macular degeneration